Factores pronósticos y predictivos en pacientes con cáncer de origen desconocido tratados con un esquema de quimioterapia con paclitaxel

Muñoz, Alberto; Fuente, Natalia; Barceló, Ramón; Rubio, Itziar; Ferreiro, Josefa; López Vivanco, Guillermo.
Med. clín (Ed. impr.) ; 122(6): 216-218, feb. 2004.
Artigo em Es | IBECS (Espanha) | ID: ibc-30374

Documentos relacionados

  1. [Genomic Analysis-Based Treatment for Cancer of Unknown Primary].
  2. Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.
  3. Cancer of Unknown Primary Presenting as Bone-Predominant or Lymph Node-Only Disease: A Clinicopathologic Portrait.
  4. Carcinoma of unknown primary: Molecular tumor board-based therapy.
  5. A case of refractory pelvic squamous cell carcinoma of unknown primary that responded to nivolumab.
  6. Rare cancers and cancer of unknown primary: Here's what you should know!
  7. Cancer of unknown primary origin; Know the enemy.
  8. From Biology to Diagnosis and Treatment: The Ariadne's Thread in Cancer of Unknown Primary.
  9. Clinical features of cancer with unknown primary site (clinical features, treatment, prognosis of cancer with unknown primary site).
  10. A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.